WO2023119237 - MANGANESE TITANATE-CONTAINING FISCHER-TROPSCH CATALYST AND METHODS FOR MAKING AND USING SAME
National phase entry:
Publication Number
WO/2023/119237
Publication Date
29.06.2023
International Application No.
PCT/IB2022/062705
International Filing Date
22.12.2022
Title **
[English]
MANGANESE TITANATE-CONTAINING FISCHER-TROPSCH CATALYST AND METHODS FOR MAKING AND USING SAME
[French]
CATALYSEUR DE FISCHER-TROPSCH CONTENANT DU DIOXYDE DE TITANE DE MANGANÈSE ET SES PROCÉDÉS DE FABRICATION ET D'UTILISATION
Applicants **
BP P.L.C.
Inventors
PATERSON, Alexander, James
VAN RENSBURG, Hendrik
Priority Data
21217619.2
23.12.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2194 | |
| EPO | Filing, Examination, Granting | 9988 | |
| Japan | Filing, Examination, Granting | 2274 | |
| South Korea | Filing, Examination, Granting | 2199 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,395
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
.[French]
.